Introduction {#s1}
============

The potential impact of breast cancer on the reproductive health of young women has become a frontline research topic in oncology and a matter of utmost importance in clinical settings. This is broadly motivated by four primary factors. First, breast cancer is the most common type of malignancy in reproductive aged women. It accounts for ∼45% of all female cancers in women aged 25--49 years ([@DMT039C9]). Breast cancer in younger women tends to be more aggressive and results in poorer prognostic outcomes ([@DMT039C23]; [@DMT039C42]). Given this scenario, adjuvant chemotherapy is commonly part of the treatment plan. Although it enhances survival, the toxic effect of chemotherapy often impairs fertility, temporary or permanently ([@DMT039C52]), or causes premature ovarian failure due to massive destruction of the ovarian reserve ([@DMT039C33]). Additionally, women are commonly advised to delay pregnancy for at least 2 years after the diagnosis, given that the majority of recurrences occur within this time range ([@DMT039C29]). Furthermore, women undergoing endocrine therapy, which commonly continues for at least 5 years and during which time a pregnancy is not recommended, may face a decrease in fertility due to age-related factors ([@DMT039C22]). Therefore, young women with a diagnosis of breast cancer face the uncertainty of whether they have the ability to become pregnant after cancer treatments. Current evidence supports that childbearing after breast cancer is not contra-indicated ([@DMT039C22]; [@DMT039C12]; [@DMT039C38]). However, individualized counselling is warranted, regarding prognosis and risk of relapse based on age and cancer pathological features, before patients can make informed reproductive decisions ([@DMT039C4]; [@DMT039C22]). Second, as a result of the improvement of screening procedures and advances in treatment, there is a growing number of survivors at childbearing age who have not yet begun or completed their families. Consequently, the issue of pregnancy and parenthood is of utmost importance. In clinical practice, gynaecologists and oncologists are frequently faced with the issue of educating women about childbearing options after breast cancer. However, some studies suggest that these professionals often feel discomfort and a lack of knowledge about how best to educate women with cancer-related fertility matters ([@DMT039C17]), leaving women\'s fertility concerns poorly addressed ([@DMT039C39]). One reason is that providers may perceive the importance of fertility as low compared with treating the cancer ([@DMT039C53]). Additionally, younger and premenopausal survivors often report higher levels of distress and lower quality of life (QOL) than older survivors ([@DMT039C55]; [@DMT039C19]; [@DMT039C27]; [@DMT039C44]). Younger women face unique physical and psychological challenges with breast cancer, including but not limited to reproductive difficulties and concerns ([@DMT039C35]; [@DMT039C18]; [@DMT039C3]; [@DMT039C39]; [@DMT039C48]; [@DMT039C10]; [@DMT039C40]). For some young survivors, the threat to their childbearing plans has major psychosocial and developmental consequences ([@DMT039C48]; [@DMT039C8]). Thus, as treatments improve and mortality declines, the ability to retain reproductive potential is becoming a major factor that women may experience during survivorship and a determinant QOL factor in an increasing number of survivors ([@DMT039C18]; [@DMT039C33]; [@DMT039C8]; [@DMT039C22]). Finally, the advent of advanced assisted reproductive technology within the oncology field has made fertility preservation an option for women, prior to the initiation of treatment.

Literature and clinical practice demonstrate that some women remain fertile and have become pregnant after a history of cancer. Additionally, there are an increasing number of options to resolve fertility complications ([@DMT039C16]; [@DMT039C43]; [@DMT039C58]). However, these methods are not always affordable due to time constrictions or personal finances, and success is not guaranteed ([@DMT039C52]). Other options are available to women who could not preserve fertility prior to treatment or for whom these efforts were unsuccessful, such as adoption and third-party reproduction for those who are unable to have biological children. However, a history of cancer may preclude some women from qualifying for adoption and third-party reproduction may be unaffordable or unacceptable to some women ([@DMT039C44]). Reproductive decisions are complex and become more complicated with a breast cancer diagnosis, given the level of uncertainty associated with this disease ([@DMT039C26]). Decisions encompass a combination of several factors that go beyond medical and physical aspects. Among those, there is the interplay of personal and psychosocial factors ([@DMT039C6]). In this context, it is paramount to understand how the experience of breast cancer shapes and influences (or not) the desire of survivors to have children. Insight into childbearing attitudes and desire for parenthood among this population will improve our ability to provide the needed educational and psychosocial support services and will aid clinicians to better assist women with their fertility-related decisions.

The purpose of this review is to highlight what is known to date about childbearing and parenthood attitudes and decisions of young breast cancer survivors from their own perspective.

Methods {#s1a}
=======

Search strategy and study selection {#s1a1}
-----------------------------------

A systematic review was conducted taking into consideration the Preferred Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines ([@DMT039C34]). Peer-reviewed journals were searched in PubMed from 1 January 1990 to 31 October 2012, limiting the search to human females. The search was conducted using combinations of these phrases or keywords: 'breast cancer survivors OR breast cancer survivorship' AND 'fertility OR reproductive issues OR childbearing OR pregnancy OR parenthood'. An identical search was replicated using PsychInf and CINAHL databases. The following selection criteria were then applied: studies conducted exclusively with young female breast cancer survivors; outcome variables being childbearing, fertility, pregnancy and parenthood attitudes/decisions after breast cancer from the women\'s perspective (studies focusing on biological or medical outcomes were excluded); studies published in the English language and primary research (review articles, conference abstracts, editorials, commentaries, correspondence or case reports were excluded). The definition of 'young' women is not consistent in the literature ([@DMT039C37]; [@DMT039C41]; [@DMT039C5]). In this review, young refers to women who were premenopausal or younger than 50 years of age. The definition of 'survivors' is also not consistent. Some research defines a woman as a survivor from the day of diagnosis ([@DMT039C2]), while others refer to a survivor as one who has completed treatment ([@DMT039C24]) and still others denote survivors as those who are 5 years post-treatment with no evidence of disease ([@DMT039C31]). For the purpose of this study, we refer to women who, at the time of the study analysis, were not receiving treatment (except endocrine therapy) and were disease free. Mixed methods, and exclusively quantitative and qualitative studies are included in this review. Studies were screened and selected for inclusion in the review according to the inclusion criteria. Articles were initially screened based on title and type of article. Abstracts of articles potentially meeting the inclusion criteria were screened for eligibility. When abstracts appeared to meet the criteria, full articles were read. Those that met all the inclusion criteria were included in the review. The search was complemented by manually searching the reference lists of studies identified in these electronic databases. Reference lists of review articles focusing on fertility issues on this targeted population were also examined ([@DMT039C41]; [@DMT039C52]; [@DMT039C1]).

Data synthesis {#s1a2}
--------------

Eligible studies were classified into three categories: quantitative studies, qualitative studies and studies using mixed methods. Data extracted from each eligible study were recorded in three standardized tables. Key information was collected on the study origin, aims, inclusion criteria, sample, study design, relevant measures/data collection and relevant findings. The three authors (V.G., I.S. and G.Q.) individually extracted data from the papers into a template containing key information for each study. The data were then discussed to ensure congruence of information extracted.

Results {#s2}
=======

Search results {#s2a}
--------------

The initial search using PubMed resulted in 493 articles, 8 of which met all the inclusion criteria and were included in the review. Searches were also carried out within PsychInfo and CINAHL databases to ensure all potential papers were reviewed. These searches did not yield any new relevant papers. Therefore, the summary of the search strategy is only presented for searches conducted in Pubmed (Fig. [1](#DMT039F1){ref-type="fig"}). Additionally, two articles were obtained by manually searching the reference lists of studies identified in the electronic databases. A total of 10 articles were included in the final review (Fig. [1](#DMT039F1){ref-type="fig"}). Among those, there were three quantitative studies, five qualitative studies and two used mixed methods. Figure 1Flow diagram illustrating the search strategy used to include studies in the review.

Overview of the included studies {#s2b}
--------------------------------

### Quantitative studies {#s2b1}

Three studies provided women\'s views, attitudes and decisions towards pregnancy and parenthood after breast cancer in a quantitative format (Table [I](#DMT039TB1){ref-type="table"}) ([@DMT039C19]; [@DMT039C20]; [@DMT039C45]). However, none of these studies had attitudes and/or decisions towards pregnancy and parenthood after breast cancer as the main outcomes. All the studies were multicentre studies, which were conducted in the USA. In total, 728 young survivors participated. The sample size exceeded 100 participants in two studies ([@DMT039C19]; [@DMT039C20]). All the studies assessed early-stage young survivors; however, participants in the [@DMT039C45] study were on average older. [@DMT039C19] also presented data for four different age groups (25--34; 35--39; 40--44 and 45--51). [@DMT039C20] failed to provide information on participants\' age range. Only one study compared a sample of survivors with healthy controls, matched on age and gravidity ([@DMT039C45]). The length of time since diagnosis varied among the studies. In the [@DMT039C19] study, survivors were on average 6 years post-diagnosis, while survivors in the [@DMT039C20] study were on average 12 years post-diagnosis. [@DMT039C45] failed to display the range of length of time since diagnosis. These authors only stated that 55% of their sample was ≥3 years post-diagnosis, failing to provide this variable range ([@DMT039C45]). Table IQuantitative studies included in the review.Study, originAimsInclusion criteriaSampleStudy designRelevant measuresRelevant findings[@DMT039C45], USAAssessment of menopausal symptoms and infertility concernsBC survivors: (i) ≤40 years diagnosis; (ii) BC ≥ 1 from diagnosis; (iii) history of chemotherapy treatment for stage I--IIIa BC; (iv) premenopausal; (v) no history of infertility or infertility treatment at diagnosis; (vi) not receiving gonadotrophin-releasing hormone-agonist therapy; (vii) no evidence of recurrence at time of survey\
Controls: (i) \<43 years; (ii) reported menses at least every 2 months; (iii) no current use of hormonal contraception; (iv) absence of comorbidity likely to affect fertility; (v) no history of invasive cancer, previous cytotoxic chemotherapy, tamoxifen use or known infertility or infertility treatment*n* = 40 (20 survivors; 20 controls)\
Mean age : 36.8 years (survivors + controls) (range 31--42 years) (SD not stated)\
55% survivors ≥3 years from diagnosis\
30% took steps to minimise infertility\
80% survivors chemotherapy interrupted their menses\
Race/ethnicity:\
Survivors group\
16 (80%) White\
1 (5%) African American/black\
0 (0%) Hispanic\
2 (10%) Asian\
0 (0%) Other (Latina)\
1 (5%) Other (West Indian)\
Control group:\
10 (50%) White\
4 (20%) African American/black\
4 (20%) Hispanic\
1 (5%) Asian\
1 (5%) Other (Latina)\
0 (0%) Other (West Indian)Cross sectional\
Survivors compared with healthy age- and gravidity matched controlsFertility Issues Survey16 survivors and 10 controls desired a future child. This desire was associated with greater fertility concerns in both survivors and controls (trend statistically significant in survivors (*P* = 0.01)\
Among women in both groups who desire a future child, survivors had more fertility concerns than controls (*P* = 0.005).[@DMT039C20], USAInvestigate whether the level of reproductive concerns after treatment is associated with long-term depressive symptoms(i) ≤40 years diagnosis, (ii) had treatment for early-stage (I-IIIa) BC within previous 4 years; (iii) completed treatment with no evidence of recurrent disease; (iv) no other cancer within 10 years of study enrolment\
Participants recruited from the WHEL Study for the WHEL Survivorship Study*n* = 131\
Mean age at diagnosis: 36.7 years (SD not stated)\
Participants completed the Survivorship Study 11.9 years (SD = not stated) post-diagnosis at 49.1 years (SD = not stated)\
Race/ethnicity:\
115 (87.8%)White\
16 (12.2%) OtherFollow-up studyCES-Dsf\
Depressive symptoms measured at baseline, 1, 2, 3, 4, 6 years of WHEL study and Survivorship Study enrolment\
\
Reproductive Concerns Scale\
Assessed at Survivorship Study enrolment27.1% (36/131) wanted a child post-diagnosis\
48.1% possibly wanted a (another) child pre-diagnosis\
18% wanted a child after and before diagnosis but were nulliparous at the time of Survivorship study\
52.7% (69/131) did not avoid pregnancy after treatment. Of those, 22% (*n* = 15) were post-menopausal at WHEL Study entry, which may have influenced their reports.\
\
7% (9/131) attempting pregnancy after treatment\
High reproductive concerns group were more likely to choose treatment based on fertility preservation (*P* = 0.05).\
Larger proportion of those in high concerns group wanted children pre- (*P* \< 0.0001) and post-diagnosis (*P* = 0.01).\
Greater reproductive concerns predicted higher levels of depressive symptoms (SE = 0.02, *P* = 0.04)\
Depressive symptoms not significantly associated with having child after cancer[@DMT039C19], USAEvaluate QOL and reproductive health outcomes in younger female BC survivors\
CAMS: main findings of the survey phase(i) Diagnosis with first invasive or non-invasive BC (ductal carcinoma *in situ*) at 50 years of age or younger; (ii) alive and disease free without a recurrence; (iii) no cancer before BC; (iv) stages 0, I or II disease; (v) living in the USA; (vi) ability to read and understand English\
Recruited 2--10 years after diagnosis*n* = 577\
(56% response rate)\
Mean age at diagnosis: 43.6 years (range: 25--51) (SD not stated)\
Mean age of study: 49.5 years (range: 30--62) (SD not stated)\
Mean time since diagnosis: 5.9 years (SD = 1.5)\
Race/ethnicity:\
405 (70.2%) White\
67 (11.6%) African American\
42 (7.3%) Hispanic\
49 (8.5%) Asian\
14 (2.4%) OtherCross-sectional studySeveral questions on reproductive history65% (373/577) had at least one live birth\
5% (17/373) reported pregnancy and live birth after BC\
11% (*n* = 61) considered getting pregnant since BC. From this:\
19% not planning pregnancy due to physician recommendation,17% not planning pregnancy due to worry about the risks,29% not planning pregnancy due to other reasons primarily related to age or personal relationship (categories not mutually exclusive), 7% trying pregnancy,17% became pregnant,12% had specific plans or treatment underway (categories not mutually exclusive)\
15% still considering pregnancy but undecided[^1]

The criteria used to methodologically appraise the studies were based on those suggested in the literature on quantitative research ([@DMT039C46]; [@DMT039C36]; [@DMT039C25]). The study design was identified and appropriately applied in each study evaluated. Two studies used a cross-sectional design ([@DMT039C19]; [@DMT039C45]) and one study was a follow-up study ([@DMT039C20]). Low response rates may potentially lead to selection bias and may compromise the representativeness of the sample. Particularly, in the [@DMT039C19] and [@DMT039C20] studies, there were significant differences between respondents and non-respondents with regard to some characteristics. [@DMT039C45] did not provide details regarding the recruitment of participants for the study. The authors simply suggested that possibly respondents and non-respondents may vary regarding fertility concerns and menopausal symptoms. In addition, in this study, survivors and controls differed significantly on marital status and education and, at a trend level, on menstrual frequency. The measures used were valid and reliable in the three studies; however, none employed a measure specifically devised to assess attitudes and decisions in this group of survivors.

### Qualitative studies {#s2b2}

Five studies provided data on young survivors\' pregnancy and parenthood attitudes and decisions after breast cancer (Table [II](#DMT039TB2){ref-type="table"}) ([@DMT039C15]; [@DMT039C47]; [@DMT039C10]; [@DMT039C21]; [@DMT039C30]). Only three studies reported experiences and perceptions related to pregnancy and having children after breast cancer ([@DMT039C15]; [@DMT039C47]; [@DMT039C10]), while the other two studies focused mainly on how health services offered had impacted women\'s experiences with breast cancer ([@DMT039C30]) and the role of fertility in their cancer treatment decisions ([@DMT039C21]). Three studies were completed in the USA ([@DMT039C15]; [@DMT039C47]; [@DMT039C21]), while the other two were conducted in Australia and the UK, respectively ([@DMT039C10]; [@DMT039C30]). Four studies used cross-sectional designs ([@DMT039C15]; [@DMT039C47]; [@DMT039C21]; [@DMT039C30]) and one study was best described as longitudinal ([@DMT039C10]). Survivors were recruited from varied contexts, including organizations ([@DMT039C47]; [@DMT039C21]), cancer centres ([@DMT039C15]; [@DMT039C47]; [@DMT039C30]), fertility services ([@DMT039C30]), breast cancer support groups ([@DMT039C10]), breast cancer events ([@DMT039C10]) and other studies, such as the Women\'s Healthy Eating and Living (WHEL) study ([@DMT039C21]). In the study by [@DMT039C10] participants were selected from the 35 women who participated in the baseline interview on the basis that their greatest unmet need was related to support. Participants in the [@DMT039C15] study were restricted to women who became pregnant after breast-conserving surgery and radiation therapy and [@DMT039C47] only included women who were deciding whether to attempt pregnancy (or had actively considered it and had made a decision within the previous 3 years) and believed that they still had the capacity to become pregnant at the time of the study. [@DMT039C21] included participants who had at least one biological child after treatment (50% of the sample) in order to ensure the inclusion of women interested in fertility. The other researchers did not consider pregnancy status as a condition to include women in their studies. In total, 178 survivors participated in these studies. Their ages at diagnosis in the five studies varied from 22 to 44 years. The length of time since diagnosis among the four studies ranged from 5 months to 13 years ([@DMT039C47]; [@DMT039C10]; [@DMT039C21]; [@DMT039C30]). The length of time since diagnosis was not provided in the [@DMT039C15] study. Table IIQualitative studies included in the review.Study, originAimsInclusion criteriaSampleStudy design, data collectionRelevant findings[@DMT039C21], USATo explore how young women make cancer treatment decisions and role of fertility concerns in that process(i) Early-stage BC survivors (stage I or II);\
(ii) ≤40 years at diagnosis*n* = 20\
Age range: 26--38 years (means, SD, medians not stated)\
7 women \<30 years\
10 women 30--34\
3 women ≥35\
Length time since diagnosis: range 1--13 years (means, SD, medians not stated)\
Participants recruited from the WHEL study and YSC\
To ensure the inclusion of women interested in fertility, half of those in the sample had at least 1 biological child after treatment\
Race/ethnicity:\
17 (85%) White\
3 (15%) HispanicCross sectional\
In dept telephone semi-structured interviews\
Cross-case analysisFertility largely viewed as secondary to the importance of survival/preventing future recurrence\
Most women interested in possibility of having children post-treatment\
At the time of interview:\
2 unable to have children; 1 trying pregnancy; 4 open to a possible pregnancy; 3 decided against having children due to older age, life circumstances, concerns about recurrence, the baby\'s health and passing on genetic risk;\
2 considering adoption\
Themes: 'I was young, I wanted to do everything possible to move forward with my life and not have the cancer come back', 'fertility concerns are different for every woman', 'my oncologist was great ... a huge part of my survivorship', 'they did not tell me about my options, and I didn\'t think about fertility until it was too late'[@DMT039C30], UKWomen\'s reactions to finding out that cancer treatment could affect fertility and how interactions with health services impacted on their ability to deal with this effectively(i) History of early-stage BC;\
(ii) ≤40 years at diagnosis; (iii) fluency in English*n* = 24\
Median age: 32 years (range: 23--39)\
Median length time since diagnosis: 32 months (range 7--72 months)\
No women of ethnic minorities recruited (although researchers approached some)Cross sectional\
3 focus groups using flexible interview structure\
Thematic analysisFertility was important; however; survival was priority over having children\
With the exception of 3 women, not having children would be better than the detrimental effects of a child not having a mother\
The majority of women thought fertility choices affected their risk of recurrence\
Themes: 'survival a priority', 'perceived risks to survival', 'advice from health professionals', 'denial of choice', 'women with children neglected', 'role of services', 'written information provision', and 'timing of discussions'[@DMT039C10],\
AustraliaExplore young women\'s issues and concerns over time\
Focus on changing views of reproductive issues over a period of 12--18 months(i) Adult female with BC;\
(ii) ≤40 years at diagnosis; (iii) English speaking;\
(iv) diagnosis ≤4 years ago; (v) not suffering extreme distress or not in palliative care or not all of thesePhase I (baseline):\
*n* = 35\
FU women:\
*n* = 13\
Median age diagnosis (FU) = 37 years (range 29--40 years)\
Median time since diagnosis = 26 months (range 5--37 months)\
Ethnicity not specifically recorded. Authors stated that participants were representative of mainstream Australia (i.e. 80% of Australian population\'s ancestry is Australian, English and Irish)Longitudinal study (data collected 3 times over a 12--18 months period)\
Home or telephone one-to-one semi-structured interviews (∼6 months apart)\
Analytical analysisWomen\'s perspectives on fertility change over time\
Mixed desire about pregnancy/wanting children\
Some women expressed fear of recurrence after pregnancy[@DMT039C47], USAWomen\'s perceptions of the possible risks and benefits of having a baby after breast cancer\
Gain insights into factors that influenced women\'s decision-making concerning pregnancy(i) Completed treatment for BC ≥ 6 months before study;\
(ii) \<46 years;\
(iii) black or white non-Hispanic;\
(iv) be currently deciding whether to attempt pregnancy (or had actively consider it and had made a decision within the previous 3 years);\
(v) believe that they still have capacity to become pregnant*n* = 50\
Median age: 33.4 years at diagnosis (range: 22--44 years)\
Median length of time since diagnosis: 33 months (range: 8 months-8 years)\
Race/ethnicity:\
42 (84%) White non-Hispanic\
8 (16%) BlackCross sectional\
In-depth focused interview, most interview questions open-ended\
Content analysis7 women pregnant since diagnosis (10 pregnancies in total)\
Most of sample contemplating pregnancy after BC, but not yet attempted to conceive\
Longer length time since treatment, more women were willing to get pregnant\
*Deterrents for pregnancy (risks/dangers):*\
'Fear their disease would recur', 'Fear the child would have birth defect because of the cancer treatment', 'Fear their child would be born with a greater susceptibility to cancer'; 'Concerns that caring for a child would be too stressful'\
*Incentives for pregnancy:*\
'Having a baby is a cherished part of a life plan'; 'Having a baby is life affirming'; 'Having a child will promote a feeling of normalcy', 'Having a baby would give her husband something that would make him very happy'; 'Having a child would improve their quality of life'[@DMT039C15],\
USAIdentify reasons why young women with BC decide to become pregnant\
Describe concerns about subsequent pregnancy\
Describe helpful behaviours in decision-making\
Explore the meaning of having children after BC(i) Early-stage BC;\
(ii) pregnancy after breast-conserving surgery and radiation therapy*n* = 16\
Mean age at diagnosis: 29.6 years at diagnosis (SD not stated) (range: 25--35 years)\
Mean age at interview: 38.8 years at diagnosis (SD not stated) (range: 32--45 years)\
Race/ethnicity:\
15 (94%) White\
1 (6%) GreekCross sectional\
Semi-structured interview\
Content analysisReasons for pregnancy related to women\'s developmental age\
Concerns related to disease recurrence, breast self-examination and mammography during pregnancy and about surviving to see their children grow up\
3 themes related to future children: 'anchoring', 'getting well again', 'feeling complete'[^2]

There is less agreement on the most appropriate method for appraising qualitative research ([@DMT039C54]). The rigour of the articles included in this review was critically evaluated using criteria for reporting qualitative research ([@DMT039C11]; [@DMT039C51]; [@DMT039C28]). The five studies included had clearly described aims and objectives and their proposed research questions were suitable to qualitative methods. Details about sampling, data collection and analysis procedures were clearly provided in the most recent studies ([@DMT039C10]; [@DMT039C21]; [@DMT039C30]). Data were collected by focus groups ([@DMT039C30]) or individual in-depth interviews, using semi-structured interview guides or open-ended questions ([@DMT039C15]; [@DMT039C47]; [@DMT039C10]; [@DMT039C21]). Two studies used content analysis ([@DMT039C15]; [@DMT039C47]), while the other three used analytical analysis, cross-case analysis and thematic analysis, respectively ([@DMT039C10]; [@DMT039C21]; [@DMT039C30]). In each of the five studies, the main findings were clearly presented. Details about reliability and validity of the results (member-checking, etc.) were provided solely in two studies ([@DMT039C10]; [@DMT039C30]). Four studies provided conclusions representing synthesis of the results, in which study limitations and avenues for further research and implications for practice were identified ([@DMT039C15]; [@DMT039C10]; [@DMT039C21]; [@DMT039C30]). None of the studies addressed the researchers\' reflexive practice, a suggested tool for improving the validity of the reported results.

### Studies using mixed methods {#s2b3}

Two studies addressed women\'s views, attitudes and decisions towards pregnancy and parenthood after breast cancer using mixed methods (Table [III](#DMT039TB3){ref-type="table"}) ([@DMT039C7]; [@DMT039C32]). [@DMT039C7] conducted a multicentre cross-sectional study in Israel. They compared a sample of 30 survivors and their husbands (*n* = 13) on positive and negative motivations towards childbirth with a sample of 29 healthy controls and their husbands (*n* = 15). The mean age of survivors in the study was 35 years (age range not reported) and the controls\' mean age was 31.7 years (age range not reported). The length of time since cancer treatment ranged from 2 to 5 years. Besides other inclusion criteria (Table [III](#DMT039TB3){ref-type="table"}), the sample was limited to women without children or with no more than two children (less than the Israeli average). There was a potential selection bias due to significant differences among survivors and controls, with respect to women\'s age and religiosity. Data were collected by means of a self-report questionnaire containing a qualitative and quantitative section. The measures included in the quantitative portion had established validity and reliability. The authors reported using content analysis to analyse the qualitative data. [@DMT039C32] provided cross-sectional data on survivors\' psychosocial concerns from the randomized control study SPIRIT (Sisters Peer Counselling in Reproductive Issues after Treatment) counselling programme ([@DMT039C50]). This study included 33 African American survivors with a mean age of 37.39 years at diagnosis (range 25--45 years). The length of time since diagnosis was not reported. The authors suggested that study participants\' were likely to be more educated, more liberal and more informed about breast cancer than the average African American survivors. Data were collected by conducting semi-structured telephone interviews that included questions regarding fertility issues. Qualitative analysis included content analysis, while quantitative analysis encompassed descriptive statistics of the interview data. The authors did not report on any psychometric properties of the questions/items within the interview guide (which would be a suggested practice for quantifying qualitative data). Both studies provided information on triangulation of the data, but failed to address researchers\' reflexive practice. Table IIIStudies using mixed methods included in the review.Study, originAimsInclusion criteriaSampleStudy design,\
data collectionRelated findings[@DMT039C32], USATo understand psychosocial concerns of young African American BC survivors(i) Self-identification as African American; (ii) ≥1 year post-diagnosis; (iii) absence of active treatment other than hormonal therapy; (iv) adequate English skills; (v) ≤45 years at diagnosis*n* = 33\
Mean age at diagnosis: 37.39 (SD = 6.00) (range 25--45 years)\
Mean age at interview: not stated\
Length time since diagnosis: not stated\
Race/ethnicity:\
33 (100%) African AmericanCross-sectional data from the RCT SPIRIT counselling programme\
Semi-structured telephone interview after participants completed the 1-year follow-up assessments at SPIRIT55% had at least 1 child at cancer diagnosis\
45% wanted a child at cancer diagnosis (retrospectively)\
48% did not recall discussing infertility with medical team\
14% (3/22 who had chemotherapy) were offered option to preserve fertility\
4 became pregnant after cancer treatment\
1 sought infertility treatment, at the time of interview was trying IVF\
2 adopted children after cancer[@DMT039C7], IsraelPositive and negative motivations towards childbirth of breast cancer survivors and their husbandsSurvivors (study group): (i) BC at Stages I--III, without metastasis;\
(ii) treatment completed at least 2 years prior to the study;\
(iii) in remission, since then or with only local recurrence;\
(iv) without other physical or mental illness;\
(v) ≤40 years old;\
(vi) premenopausal or no indication of being menopausal;\
(vii) without children or ≤2 (less than the Israeli average);\
(viii) Jewish, Hebrew speaking and living in Israel more than 10 years\
Controls: (i) without other physical or mental illness;\
(ii) ≤40 years old;\
(iii) premenopausal or no indication of being menopausal;\
(iv) without children or ≤2;\
(v) Jewish, Hebrew speaking and living in Israel more than 10 yearsStudy group: recruitment in 3 hospitals\
Control group (healthy women), convenience sample recruited from the community, hospitals and university\
*n* = 30 survivors + 13 survivors\' husbands\
Survivors group: 35 years mean age (SD = 3.1)\
Survivors group (husbands): mean age of 38.2 years (SD = 2.9)\
Treatment completed: range 2--5 years before study\
*n* = 29 controls + 15 controls\' husbands\
Control group: mean age of 31.7 years (SD = 3.9)\
Control group (husbands): mean age of 35.2 years (SD = 4.9)\
Details on race/ethnicity not reportedCross-sectional study\
BC survivors and husbands compared with healthy women and their husbands\
Data collection:\
(1) Qualitative component: participants list 3 reasons against and in favour of having children\
(2) Quantitative component :\
PMQ-R\
EMS\
BSI\
IES\
MAC*Quantitative data:*\
No differences between groups about negative and positive motivations\
No differences between groups in the desire for children\
Survivors desired less number of children than controls (*F*(1,49) = 4.86, *P* \< 0.05)\
Survivors\' husbands desired less number of children than controls\
(*F*(1,25) = 16.67, *P* \< 0.001)\
*Qualitative data:*\
*Positive motivations BC survivors:*\
Immortality, big family, siblings for their existing children, happiness and giving meaning to life\
BC survivors\' unique positive motivations compared with controls: desire to have siblings for their existing children and strong desire to have a big family. Happiness was less reported compared with controls\
*Negative motivations BC survivors:*\
Mother\'s health, child\'s health, financial concerns, personal restrictions and world view.\
BC survivors unique negative motivations compared with controls: concerns over mother\'s health (most reported motivation). Concerns over child\'s health were more reported and pessimistic world view, personal restrictions and immaturity were less reported than in controls\
Positive motivations not correlated with mental distress. Negative motivations correlated with mental distress only in husbands of BC survivors (*r* = 0.66, *P* \< 0.05)BC did not impede overall positive motivations, nor increased negative motivations towards childbirth[^3]

Young survivors\' attitudes and decisions towards pregnancy and having children after breast cancer {#s2c}
---------------------------------------------------------------------------------------------------

Collectively, the studies reviewed documented that childbearing is an important issue for many young survivors. However, in general, there were mixed views and perceptions about this issue.

### Positive attitudes {#s2c1}

Some findings demonstrated that survivors viewed pregnancy and parenthood positively ([@DMT039C47]; [@DMT039C7]; [@DMT039C10]; [@DMT039C21]; [@DMT039C45]; [@DMT039C32]). Two studies compared survivors with healthy controls ([@DMT039C7]; [@DMT039C45]). In the [@DMT039C45] study, 16 survivors (*n* = 20) and 10 age- and gravidity-matched controls (*n* = 20) desired a future child. The desire to have a child in the future was associated with more fertility concerns in both survivors and controls, though this trend was only significant for survivors. The study conducted by [@DMT039C7] did not find differences between survivors and their husbands in either the survivor or control group regarding their desire for children. However, survivors and their husbands desired significantly fewer children than controls ([@DMT039C7]). Some qualitative studies suggested that most of women in their samples were interested in having children after treatment ([@DMT039C47]; [@DMT039C21]) and were delighted when pregnancies occurred ([@DMT039C10]). In the [@DMT039C21] study, all women who were childless (*n* = 10) reported possibly (*n* = 9) or definitely (*n* = 1) wanting a child after treatment. At the time of the study, two women were not able to have a child, four were still welcoming that possibility, one was trying to become pregnant, three decided not to have children and two were considering adoption (but none had adopted a child). [@DMT039C32] reported that almost half of their sample desired children at diagnosis; however, few women became pregnant post-treatment or pursued means to become a parent (adoption or fertility preservation techniques). This was mostly attributed to cultural stigma related to African Americans for whom the importance of fertility was often dismissed by health professionals ([@DMT039C32]).

### Negative attitudes {#s2c2}

Two qualitative studies showed that the issue of pregnancy and parenthood after breast cancer may also evoke negative views and attitudes in some survivors ([@DMT039C10]; [@DMT039C30]). In the [@DMT039C10] study, some participants who became pregnant during the study considered terminating the pregnancy. In another study, with the exception of three women, participants felt that not having a child would be better than the negative effects of a child not having a mother. These women\'s thoughts about childbirth were influenced by their perceptions about survival risks, which appeared to be increased by conflicting views and advice given to them by different health professionals. Women who were childless were more likely to prioritize fertility over survival ([@DMT039C30]). Following this line, quantitative findings showed that although some survivors reported having children or hoping to have children after treatments, several decided against becoming pregnant. In the Gorman *et al*. study ([@DMT039C20]), 27% of participants (36/131) wanted a child (or more children) after diagnosis, while a larger proportion (48%) stated wanting a child (or more children) before diagnosis. Additionally, 53% (69/131) did not avoid pregnancy after treatment; however, as researchers noted, 22% (15/131) of those were post-menopausal at the study entry, which might have introduced bias in this report. Only 7% of women in this study (9/131) reported trying to become pregnant after treatment. Another study investigated QOL and health outcomes, with a specific focus on the reproductive and late health effects of treatment, in a large cohort of 577 survivors ([@DMT039C19]). Reproductive details of participants revealed that 373 women (65%) reported at least one live birth but only 5% of these (17/373) had became pregnant and had a child after breast cancer. Of all of the survivors, another 20% reported that they were planning or hoping to have children before diagnosis, whereas only 11% (*n* = 61) had considered pregnancy since the diagnosis. Among these 61 survivors, some were not planning to become pregnant due to physicians\' recommendations (19%), worries about risks (17%) and other reasons mainly related to age and/or personal relationship circumstances (29%, these categories were not mutually exclusive). Only 7% of these women were attempting to become pregnant; 17% had became pregnant and 12% had specific plans or fertility treatments underway (these categories were not mutually exclusive) ([@DMT039C19]).

### Uncertainty about future pregnancy and desiring a child {#s2c3}

Mixed perceptions about desiring a child were expressed by some survivors. These were fuelled by thoughts related to their possible shorter lifespan and feelings of guilt and selfishness. Remaining fertile after cancer also triggered anxiety in some women, raising concerns for safe and reliable contraception. Women with a shorter length of time since diagnosis were more likely to be uncertain about their reproductive plans at the time of the study, but wanted to have the option open for the future, while women with a longer time since their diagnosis were more likely to have already made their reproductive choices ([@DMT039C10]). Although fertility and parenthood were important for many survivors, qualitative data showed survival was the main priority when making treatment-related decisions ([@DMT039C10]; [@DMT039C21]; [@DMT039C30]). Uncertainty regarding whether to have a child or not was captured by [@DMT039C19], who reported that 15% of survivors in their study were still considering having a child but had not yet decided.

Pregnancy and parenthood after breast cancer: perceived risks and benefits {#s2d}
--------------------------------------------------------------------------

### Risks {#s2d1}

The studies documented some concerns or fears that women held towards becoming pregnant and having children after breast cancer ([@DMT039C15]; [@DMT039C47]; [@DMT039C19]; [@DMT039C7]; [@DMT039C10]; [@DMT039C21]; [@DMT039C30]; [@DMT039C45]). These fears or concerns were the main reason many women decided against having children. One of the most commonly cited fears was that pregnancy may enhance cancer recurrence ([@DMT039C15]; [@DMT039C47]; [@DMT039C7]; [@DMT039C10]; [@DMT039C21]; [@DMT039C30]; [@DMT039C45]). Specifically, women were afraid that hormonal changes brought on by the pregnancy could stimulate a cancer recurrence. Fears of recurrence were expressed in relation to women\'s mortality ([@DMT039C15]; [@DMT039C47]; [@DMT039C10]; [@DMT039C21]) and in the reduction of their survival chances ([@DMT039C30]). Given this concern, women wondered if it was morally right ([@DMT039C47]) or if they were being selfish by having a child when their mother could experience a premature death ([@DMT039C47]; [@DMT039C10]). Some participants expressed that even if they did not die after recurrence, it would be a significant emotional burden for a young child to have a mother so seriously ill ([@DMT039C47]). Furthermore, some women with children felt that they could not jeopardize their current children\'s QOL by putting their own health at risk ([@DMT039C47]; [@DMT039C30]). A specific concern expressed by participants was the inability to detect any significant breast changes during pregnancy ([@DMT039C15]; [@DMT039C10]) and not being able to have mammograms during pregnancy. The only study that compared motivations towards childbirth of survivors and their husbands and controls found that concerns over the mother\'s health was a negative motivation confined uniquely to the survivors group. This also corresponded to their most frequently reported negative motivation towards childbirth ([@DMT039C7]).

Fears related to the health of a child born after breast cancer were also common ([@DMT039C15]; [@DMT039C47]; [@DMT039C7]; [@DMT039C21]). Women worried that the child might be born with a birth defect because of the chemotherapeutic agents that they received or their previous exposure to toxins and radiation ([@DMT039C15]; [@DMT039C47]). Furthermore, women expressed fears that the child would have a greater susceptibility to being diagnosed with childhood cancer or breast cancer as an adult. Several women worried about genetically passing on a general susceptibility to cancer to their offspring. These fears were associated with concerns about whether it would be selfish or morally right to have a child at risk for cancer ([@DMT039C47]). [@DMT039C15] found that women who had children after breast cancer became hypervigilant towards their child\'s health. In contrast to [@DMT039C47], these participants did not focus greatly on their children\'s potential risk of developing cancer. [@DMT039C15] had advocated that one of the possible reasons for this was poor knowledge about genetic risks of breast cancer at the time of the study. Survivors reported more negative motivations towards childbirth related to concerns over the child\'s health compared with controls ([@DMT039C7]). Additional concerns included not having a normal pregnancy ([@DMT039C15]), lacking the energy to provide the level of care and involvement the survivor would desire to offer to her children ([@DMT039C47]), life circumstances ([@DMT039C21]), older age ([@DMT039C21]), financial concerns ([@DMT039C7]), pessimistic world view ([@DMT039C7]) and personal restrictions ([@DMT039C7]). However, when compared with healthy women, survivors expressed less negative motivations due to pessimistic world views, personal restrictions and feelings of immaturity ([@DMT039C7]).

### Benefits {#s2d2}

Young survivors also perceived important benefits that could be achieved by becoming pregnant and having a child after breast cancer ([@DMT039C15]; [@DMT039C47]; [@DMT039C7]; [@DMT039C10]). Many women stated that one of the reasons for desiring a child was that having a baby was a cherished goal of a life plan ([@DMT039C15]; [@DMT039C47]). They had a longstanding desire to have a child or family, which was interrupted but not altered by the illness. For those women, this represented an important life goal that they wanted to pursue.

Another potential benefit to having children after breast cancer was that raising a child would be a powerful motivator to stay alive and healthy. Some women expressed that a child would give them more hope and optimism about the future ([@DMT039C15]; [@DMT039C47]; [@DMT039C10]). A related benefit would be a desire for a sense of normalcy in their lives achieved through childbirth. Besides giving them the opportunity to reconnect with their peers who were having or raising children ([@DMT039C15]; [@DMT039C47]), bearing a child would restore their sense of normal femininity and sexuality, as well as increasing their sense of self-worth ([@DMT039C47]).

Other motivating factors included the desire to make a husband happy ([@DMT039C47]), the improvements in survivors\' QOL ([@DMT039C47]), the absence of a compelling reason for not having children ([@DMT039C15]), symbolic immortality, desire to have a big family, desire to have siblings for existing children, achieving happiness and giving meaning to life ([@DMT039C7]). The desire to have siblings for their existing children was a positive motivation limited uniquely to survivors when compared with controls ([@DMT039C7]). Survivors expressed more positive motivations towards having a big family than controls. In addition, survivors reported the desire to feel happiness less often than healthy women. Survivors were less likely to report the relationship with their husbands as a positive motivation to have children compared with healthy women who did report this desire. Positive motivations towards childbirth were not affected by mental distress ([@DMT039C7]).

Meaning of parenthood after breast cancer {#s2e}
-----------------------------------------

One of the first qualitative studies conducted with a population of breast cancer survivors attempted to collect data on the meaning of having children for young survivors ([@DMT039C15]). Three themes emerged: anchoring, getting well again and feeling complete. The results showed women perceived having a child would help anchor their lives in a very positive way and would help them focus on their practical daily activities. Further, they perceived a child would help them to stay well, feel complete and look forward to the future, which is the opposite of what survivors reported a cancer diagnosis might mean for them (concerns about dying in the future).

Discussion {#s3}
==========

This review sought to improve our understanding about pregnancy and parenthood attitudes, views and decisions of young breast cancer survivors by examining quantitative and qualitative findings. Although data on attitudes and intentions do not always reflect actual behaviour, it provides important insights into the thoughts, views and needs of those women. From the studies reviewed, it is apparent that childbearing after breast cancer is an important and sensitive matter for young survivors. Collectively, the study findings reflected survivors\' mixed attitudes and perceptions towards this subject. While on the one hand some women welcomed the idea of becoming pregnant and having (more) children, some women were against this idea after experiencing cancer. Other women were unsure and could not make these decisions yet. Fuelling these attitudes and decisions were often women\'s perceptions about the risks that a pregnancy would carry to cancer recurrence and, ultimately, to their survival. Fear that a possible pregnancy would increase the chance of recurrence was reported even among women who held positive attitudes towards childbirth ([@DMT039C15]; [@DMT039C10]). However, while some studies reported that pregnancy may mean fear, risks and eventually premature death, other studies supported the view that pregnancy may also mean happiness, normalcy and a fulfilling life. Therefore, pregnancy and parenthood seem to represent, in many respects, the opposite of a cancer diagnosis for several survivors. In fact, the ability to have children after treatment is a concern for many women, even for those who were against having children ([@DMT039C30]).

It has been nearly 20 years since [@DMT039C15] published one of the first attempts to understand why young women decided to have children after breast cancer. Since then, unfortunately, a limited number of studies have explored this subject. The majority of studies reviewed provided details on pregnancy and parenthood attitudes and decisions, but their main focus was on other health outcomes. This was particularly true for quantitative studies. Most of the data pertaining to attitudes, views and decisions in this review were obtained through qualitative methods. Qualitative methods provide valuable insight and the ability to capture in-depth information about a subject. Given that the literature has now provided a good sense of the survivors\' range of attitudes and perceptions on this topic, there is a clear need to expand the literature with quantitative methods using validated and reliable assessments of attitudes in large representative samples of participants. In this review, we were unable to find a study that used a valid and reliable measure to assess pregnancy and parenthood attitudes specifically after breast cancer. Thus, the development of such an instrument would be a highly useful tool for clinicians.

There are additional other relevant methodological limitations to the quantitative studies reviewed. With the exception of the [@DMT039C19] study, samples were generally small. In addition, these samples were heterogeneous regarding the length of time since diagnosis or treatment and pregnancy status, which prevented us drawing firm conclusions from their findings. It is recommended that future studies compare groups of survivors by disease stage at diagnosis, age or pregnancy status. Few studies included samples of controls, and the few who did reported problems in matching their samples, which may lead to selection bias. Methodological limitations of the qualitative studies included a lack of information about data trustworthiness and none of the researchers informed readers about their use of reflexive practice. Only one of the studies in this review examined women\'s perceptions at more than one point in time and it is likely attitudes may fluctuate over the cancer trajectory. Therefore, we suggest that it would be of utmost importance to capture this variability in a prospective longitudinal study. Additionally, most of the literature has been produced in the USA and it is highly likely there are cultural differences in attitudes. More studies are needed with populations of women from other countries. Specifically, as minorities are underreported in existing research, future efforts should be made to include these minority populations and under-served women in their samples. Further, all the studies in this review were retrospective. While it can be ethically challenging to potentially burden women with surveys and requests for interviews at the time of diagnosis and throughout treatment, it is very important to capture the prospective attitudes of women who are newly diagnosed or undergoing treatment. Such data will improve clinicians\' ability to provide guidance and education on fertility preservation or other assisted reproductive technologies.

Given the increasing interest and importance surrounding fertility issues in the context of cancer care, conducting a systematic review about childbearing attitudes and decisions among breast cancer survivors is timely and relevant. Our review provides a valuable overview about this topic; however, it has some limitations. First, despite the efforts made during the search process, it is probable that some studies were not identified. Furthermore, only peer-reviewed papers were screened, which excluded unpublished studies and those studies published in non-peer-reviewed journals. Second, we only included studies published in the English language and it is possible important contributions to this field have been published in other languages. Finally, the small number of studies identified for the review and the dominance of studies conducted in the USA are also a limitation of the current body of research. Despite these limitations, our review offers the first systematic compilation of data specifically on this topic, opening avenues to strengthen future research and clinical practice. Consideration of our findings will be essential to develop and improve educational tools and psychosocial support services appropriated to survivors\' needs.

Conclusions and implications for clinical practice and future research {#s3a}
----------------------------------------------------------------------

Our review highlights the importance of addressing childbearing and parenthood attitudes in young breast cancer survivors. It supports the need for frank discussions among health professionals and women, especially since many attitudes and views may be based on misinformation about pregnancy-associated risks. Women need and want fertility information in a timely manner ([@DMT039C39]), which may help to ameliorate their fertility concerns ([@DMT039C7]). This may constitute a valuable aid when making informed decisions. Literature advocates that one of the most important factors in the complex process of decision-making in cancer management is the patient preference ([@DMT039C17]; [@DMT039C56]). Following this line, a true understanding or effort to understand patient\'s attitudes towards pregnancy and parenthood is a matter of clinical urgency when dealing with fertility issues. This provides the opportunity to deliver the care that fits patients\' needs and preferences, their system of belief ([@DMT039C56]) and ultimately, improve their QOL. Given the limited current body of research, more studies need to be conducted in order to understand, with more depth and precision, women\'s perceptions on fertility and parenthood after the experience of breast cancer. Knowledge about this topic will remain low unless a framework or theory that attends to the different variables that possibly influence survivors\' attitudes and decisions is provided.

The growing interest in research and clinical practice on the application of the use of fertility preservation techniques in oncology patients should take into consideration the value that these patients place on the ability to have and parent a child after cancer ([@DMT039C49]; [@DMT039C57]). The value of adoption and third-party reproduction for these survivors has not been thoroughly investigated, although preliminary studies in this field suggest survivors prefer biological children when possible ([@DMT039C49]; [@DMT039C57]). The options for having children after breast cancer using adoption, fertility preservation or other types of assistive reproductive technologies involve complex and difficult decisions, in which personal values and cultural and religious preferences play a pivotal role. With regard to fertility preservation techniques, decisions often have to be made quickly, such as whether to preserve oocytes or embryos, and dealing with these complex decisions in the midst of a cancer diagnosis can be overwhelming ([@DMT039C58]). Decisions about using fertility preservation necessitate a woman be fully informed about potential fertility risks due to treatment. Further, fertility preservation options yield the best results when undertaken prior to cancer treatment but in some cases may require a delay in treatment. In addition, health-care providers may need to inform patients considering fertility preservation about future choices, based on their current decisions such as the fate of unused cryopreserved oocytes or embryos in the event of the survivors death ([@DMT039C58]).

To finalize, we recommend future larger and more rigorous studies that not only overcome methodological flaws identified in the existing research but also bring new dynamics to this topic, such as for example investigating the need and efficacy for psychosocial interventions that could target women who have positive attitudes towards fertility and parenthood but are unable to conceive. Fertility for breast cancer survivors is a relevant matter. For some women, infertility due to cancer treatments can be a devastating psychological challenge. The importance of identifying women at high risk for distress is a mandatory duty for those involved in their clinical care.
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